Chime Biologics, a global biologics contract development and manufacturing organisation (CDMO), has announced the inaugu...
Avance Clinical, the Australian-headquartered global Contract Research Organization (CRO) for biotechs, today announced ...
WuXi Biologics’ Suzhou Biosafety Testing Center has passed a European Medicines Agency Good Manufacturing Practice...
Germany-based ZEISS Medical Technology held a signing ceremony with the Aier Eye Hospital Group, China, entering into a ...
A research team led by Hong Kong Baptist University (HKBU) has discovered that extracts from the Justicia Chin...
Inflammatory bowel disease is becoming a growing focus within immunology innovation across Asia-Pacific, as the region s...
A research team from The Hong Kong University of Science and Technology (HKUST), together with an HKUST-incubated m...
China-based Simcere Pharmaceutical Group has entered into a research collaboration agreement with Stanford Medicine, US ...
China-based QingSong Health Corp and Basel Medical Group have announced the signing of a Memorandum of Strateg...
China-based Everest Medicines has entered into an exclusive licensing agreement with Jiangsu Vcare PharmaTech Co., ...
LongBio Pharma, a portfolio company of Qiming Venture Partners and a leading innovative drug developer for allergic and ...
Australia-based Gelteq has announced the establishment of a new Gelteq Centre of Excellence in Guangdong Province, China...
Shanghai Henlius Biotech and Organon have received European Commission marketing authorisation for POHERDY, a pertuzumab...
China-based Everest Medicines has entered into an exclusive licensing and collaboration agreement with US-based Travere ...
China-based Haisco Pharmaceutical Group has announced a licensing and research collaboration with American firm Eli Lill...
Biond Biologics, a private clinical-stage biotechnology company developing first-in-class immunotherapies for cance...
China-based Innovent Biologics and American firm Pfizer Inc. have entered into a strategic global licensing and collabor...
Samsung Epis Holdings Co., an investment holding company dedicated to innovation in biopharmaceuticals and biotechnology...
Insilico Medicine, a Hong Kong-headquartered clinical-stage generative artificial intelligence (AI)-driven biotechnology...
Cornerstone Robotics (CSR), a leading global innovator in surgical robotics based in Hong Kong, China, has announced tha...
On May 15, 2026, China’s National Medical Products Administration (“NMPA”) issued the Implementat...
Accro Bioscience Inc., a China-based clinical-stage biotechnology startup pioneering the development of novel thera...
The Hong Kong Hub of Obstetric and Paediatric Excellence (HOPE) at The Chinese University of Hong Kong (CUHK) and Hangzh...
Shanghai Fosun Pharmaceutical (Group) and South Korea-based AriBio Co., a biopharmaceutical company focused on neurodege...
METiS TechBio, a tech-bio company focused on AI-powered nanodelivery innovation, has successfully listed on the Hong Kon...
